Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+15.9%
5Y CAGR+30.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+15.9%/yr
vs +84.6%/yr prior
5Y CAGR
+30.2%/yr
Recent deceleration
Acceleration
-68.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
7 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $68.20M | +7.3% |
| 2024 | $63.53M | +15.4% |
| 2023 | $55.04M | +25.6% |
| 2022 | $43.83M | +20.6% |
| 2021 | $36.34M | +99.3% |
| 2020 | $18.23M | +128.5% |
| 2019 | $7.98M | +111.6% |
| 2018 | $3.77M | - |